The Centers for Medicare & Medicaid Services released details of its proposal to address the expensive costs of Medicare Part B.
Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.
TrumpRx: Discover how Trump's new agreements with major pharmaceutical companies aim to lower prescription drug costs for ...
In his latest effort to lower drug costs, President Donald Trump unveiled Friday “Most Favored Nation” pricing deals with nine more pharmaceutical companies.
“Starting next year, American drug prices will come down fast and furious and will soon be the lowest in the developed world, ...
On December 1, 2025, the Office of the United States Trade Representative, the Department of Commerce, and the Department of Health and Human Services announced an agreement with the United Kingdom (U ...
Under the deals, each drugmaker will cut prices on most drugs sold to the Medicaid program for low-income people, senior ...
Medicare enrollees will save more than 50% on out-of-pocket costs for 10 common prescription drugs under their insurance ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback